| Phase 3 |
| NCT07377578 |
A Study of Rocbrutinib Versus Investigator's Choice of BTK Inhibitors in Patients With… |
Mantle Cell Lymphoma |
Recruiting |
2026-02-06 |
| Phase 2 |
| NCT07776743 |
A Study of Rocbrutinib in PRL-Positive Relapsing-Remitting Multiple Sclerosis |
Relapsing-remitting Multiple Sclerosis (RRMS) |
Recruiting |
2026-08-20 |
| NCT07609823 |
A Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL |
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
Recruiting |
2026-07-30 |
| NCT07189065 |
A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large… |
Diffuse Large B-Cell Lymphoma (DLBCL) |
Recruiting |
2025-12-16 |
| NCT05716087 |
A Study of Rocbrutinib in Participants With Relapse or Refractory Mantle Cell Lymphoma |
Mantle Cell Lymphoma (MCL) |
Active, Not Recruiting |
2026-01-15 |
| Phase 1/2 |
| NCT07609862 |
A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies |
Mantle Cell Lymphoma (MCL) |
Recruiting |
2026-07-30 |
| Phase 1 |
| NCT07374224 |
A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic… |
Clinical Pharmacology |
Recruiting |
2026-03-09 |
| NCT04993690 |
A Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma |
B-cell Lymphoma |
Recruiting |
2025-09-23 |
| NCT06251180 |
Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed… |
B-cell Non-Hodgkin Lymphoma |
Recruiting |
2025-03-25 |
| NCT07570017 |
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory… |
DLBCL |
Not Yet Recruiting |
2026-05-06 |
| NCT05130567 |
A Study of LP-128 Capsules in Healthy Subjects |
Chronic Hepatitis b |
Active, Not Recruiting |
2025-04-03 |